Anticoagulation Reversal for ICH

June 24, 2019 • 00:26:09
Anticoagulation Reversal for ICH
Critical Care Perspectives in Emergency Medicine
Anticoagulation Reversal for ICH

Jun 24 2019 | 00:26:09

/

Show Notes

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50 percent at 1-year, with many left with significant residual deficits.  Patients with an ICH who are taking an oral anticoagulant medication tend to have larger ICH volumes, more frequent IVH, and a greater frequency of hematoma expansion.  In this podcast, we review the latest recommendations on reversing anticoagulant medications in patients with an ICH. This is information you can’t afford to miss!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

July 04, 2018 • 00:23:41
Episode Cover

Pearls for the Management Heatstroke

The heat and humidity have returned to the Northern Hemisphere!  Numerous deaths have already been reported due to the extreme heat.  In this episode...

Listen

Episode 0

March 08, 2021 • 00:28:05
Episode Cover

COVID-19 Updates March 2021

In recent weeks, there have been several important studies and guidelines published that have served to improve our understanding of treating critically ill patients...

Listen

Episode 0

February 18, 2020 • 00:19:11
Episode Cover

Roc vs. Sux - The CURASMUR Trial

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial...

Listen